DrugPatentWatch Database Preview
RETISERT Drug Patent Profile
Email this page to a colleague
When do Retisert patents expire, and when can generic versions of Retisert launch?
Retisert is a drug marketed by Bausch And Lomb and is included in one NDA.
The generic ingredient in RETISERT is fluocinolone acetonide. There are twelve drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Retisert
A generic version of RETISERT was approved as fluocinolone acetonide by TARO on April 27th, 1982.
Summary for RETISERT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 68 |
| Clinical Trials: | 9 |
| Patent Applications: | 4,170 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for RETISERT |
| What excipients (inactive ingredients) are in RETISERT? | RETISERT excipients list |
| DailyMed Link: | RETISERT at DailyMed |
Recent Clinical Trials for RETISERT
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| St. Michael's Hospital, Toronto | Phase 2 |
| Pradeepa Yoganathan | Phase 2 |
| Unity Health Toronto | Phase 2 |
Pharmacology for RETISERT
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for RETISERT
US Patents and Regulatory Information for RETISERT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | RETISERT | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 021737-001 | Apr 8, 2005 | RX | Yes | Yes | ⤷ Try it Free | ⤷ Try it Free | ⤷ Try it Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RETISERT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch And Lomb | RETISERT | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 021737-001 | Apr 8, 2005 | ⤷ Try it Free | ⤷ Try it Free |
| Bausch And Lomb | RETISERT | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 021737-001 | Apr 8, 2005 | ⤷ Try it Free | ⤷ Try it Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RETISERT
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2367092 | ⤷ Try it Free |
| World Intellectual Property Organization (WIPO) | 0056340 | ⤷ Try it Free |
| Australia | 2005200243 | ⤷ Try it Free |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for RETISERT
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2233112 | 132014902285293 | Italy | ⤷ Try it Free | PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
